Cost-related medication nonadherence in older patients with rheumatoid arthritis

Journal of Rheumatology

Volumn 40, Issue 2, 2013, Pages 137-143

  Harrold, Leslie R ^a   Briesacher, Becky A ^a   Peterson, Dan ^a   Beard, Ashley ^b   Madden, Jeanne ^c   Zhang, Fang ^c   Gurwitz, Jerry H ^a   Soumerai, Stephen B ^c  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c HARVARD PILGRIM HEALTH CARE INSTITUTE   (United States)

Author keywords

Adherence; Biologics; Costs; Disease modifying antirheumatic drugs; Rheumatoid arthritis

Indexed keywords

ANTIRHEUMATIC AGENT;

ADULT; AGED; ARTICLE; BASIC NEEDS; CHRONIC DISEASE; COMORBIDITY; DRUG COST; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SELF REPORT;

AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG COSTS; FEMALE; HEALTH SURVEYS; HUMANS; INCOME; INSURANCE, PHARMACEUTICAL SERVICES; MALE; MEDICARE; MEDICATION ADHERENCE; MIDDLE AGED; PRESCRIPTION DRUGS; PREVALENCE; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84873603478     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.120441     Document Type: Article

References (28)

1. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I. Arthritis Rheum 2008;58:15-25.
2. Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): A single-blind randomised controlled trial. Lancet 2004;364:263-9.
3. Verstappen SM, Jacobs JW, van der Veen MJ, Heurkens AH, Schenk Y, ter Borg EJ, et al; Utrecht Rheumatoid Arthritis Cohort study group. Intensive treatment with methotrexate in early rheumatoid arthritis: Aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). Ann Rheum Dis 2007;66:1443-9.
4. Consumerreports.org. Treating the symptoms of rheumatoid arthritis: The biologics. 2010. [Internet. Accessed October 22, 2012]. Available from: http://www.consumerreports.org/health/resources/pdf/best-buy-drugs/ BBD-Rheumatoid-Arthritis.pdf
5. Vera-Llonch M, Massarotti E, Wolfe F, Shadick N, Westhovens R, Sofrygin O, et al. Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to methotrexate. Rheumatology 2008;47:535-41.
6. Drug topics. In: Red book: pharmacy's fundamental reference. Montvale, NJ: Medical Economics Inc.; 2006.
7. Safran DG, Neuman P, Schoen C, Kitchman MS, Wilson IB, Cooper B, et al. Prescription drug coverage and seniors: Findings from a 2003 national survey. Health Aff 2005; Suppl Web Exclusives: W5-152-W5-166.
8. Safran DG, Neuman P, Schoen C, Montgomery JE, Li W, Wilson IB, et al. Prescription drug coverage and seniors: How well are states closing the gap? Health Aff 2002; Suppl Web Exclusives: W253-68.
9. Soumerai SB, Pierre-Jacques M, Zhang F, Ross-Degnan D, Adams AS, Gurwitz J, et al. Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: A national survey 1 year before the Medicare Drug Benefit. Arch Intern Med 2006;166:1829-35.
10. Polinski JM, Mohr PE, Johnson L. Impact of Medicare Part D on access to and cost sharing for specialty biologic medications for beneficiaries with rheumatoid arthritis. Arthritis Rheum 2009;61:745-54.
11. Adler GS. A profile of the Medicare Current Beneficiary Survey. Health Care Financ Rev 1994;15:153-63.
12. Bambauer KZ, Safran DG, Ross-Degnan D, Zhang F, Adams AS, Gurwitz J, et al. Depression and cost-related medication nonadherence in Medicare beneficiaries. Arch Gen Psychiatry 2007;64:602-8.
13. Madden JM, Graves AJ, Zhang F, Adams AS, Briesacher BA, Ross-Degnan D, et al. Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D. JAMA 2008;299:1922-8.
14. Zivin K, McCammon RJ, Davis MM, Halasyamani LK, Kales HC. Increases in Medicare prescription drug plan costs attributable to psychotropic medications. Am J Geriatr Psychiatry 2008;16:674-85.
15. Centers for Medicare and Medicaid Services, U.S. Department of Health and Human Services. Health and Healthcare of the Medicare Population: Data from the 2003 Medicare Current Beneficiary Survey. Rockville, MD: U.S. Department of Health and Human Services; December 2006; (Westat) 227-38.
16. Sarndal CE, Swensson B, Wretman J. Unbiased estimation for cluster sampling and sampling in two or more stages. In: Model assisted survey sampling (Springer Series in Statistics). 2nd ed. New York: Springer-Verlag; 1992:150-3.
17. Madden JM, Graves AJ, Ross-Degnan D, Briesacher BA, Soumerai SB. Cost-related medication nonadherence after implementation of Medicare Part D, 2006-2007. JAMA 2009;302:1755-6.
18. Lurie IZ, Dunlop DD, Manheim LM. Trends in out-of-pocket medical care expenditures for Medicare-age adults with arthritis between 1998 and 2004. Arthritis Rheum 2008;58:2236-40.
19. Wolfe F, Allaire S, Michaud K. The prevalence and incidence of work disability in rheumatoid arthritis, and the effect of anti-tumor necrosis factor on work disability. J Rheumatol 2007;34:2211-7.
20. Trends Rx Report. Northbrook, IL: Caremark; 2006. [Internet. Accessed October 22, 2012.] Available from: www.caremark.com/portal/asset/2006- TrendsRxReport.pdf
21. Harrold LR, Peterson D, Beard AJ, Gurwitz JH, Briesacher BA. Time trends in medication use and expenditures in older rheumatoid arthritis patients. Am J Med 2012;125:937.
22. Karaca-Mandic P, Joyce GF, Goldman DP, Laouri M. Cost sharing, family health care burden, and the use of specialty drugs for rheumatoid arthritis. Health Serv Res 2010;45:1227-50.
23. Mojtabai R, Olfson M. Medication costs, adherence, and health outcomes among Medicare beneficiaries. Health Aff 2003; 22:220-9.
24. Chernew ME, Rosen AB, Fendrick AM. Value-based insurance design. Health Aff 2007;26:w195-203.
25. Alexander GC, Casalino LP, Meltzer DO. Patient-physician communication about out-of-pocket costs. JAMA 2003;290:953-8.
26. Beard AJ, Sleath B, Blalock S, Roth M, Weinberger M, Tudor G, et al. Predictors of rheumatoid arthritis patient-physician communication about medication costs during visits to rheumatologists. Arthritis Care Res 2010;62:632-9.
27. Katz JN, Barrett J, Liang MH, Bacon AM, Kaplan H, Kieval RI, et al. Sensitivity and positive predictive value of Medicare Part B physician claims for rheumatologic diagnoses and procedures. Arthritis Rheum 1997;40:1594-600.
28. Losina E, Barrett J, Baron JA, Katz JN. Accuracy of Medicare claims data for rheumatologic diagnoses in total hip replacement recipients. J Clin Epidemiol 2003;56:515-9.